Osaic Holdings
VIVO

Osaic Holdings’s Meridian Bioscience Inc VIVO Stock Holding History

Osaic Holdings’s Portfolio VIVO Stock Details VIVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-15
Closed -$1K – 7027
2020
Q4 		$1K Hold
15
– – ﹤0.01% 6326
2020
Q3 		$3K Buy
+15
New +$292 ﹤0.01% 5790

Other funds holding VIVO

BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Osaic Holdings's VIVO Position: Q1 2023 in Review

Osaic Holdings sold out of Meridian Bioscience Inc (VIVO) in Q1 2023, closing a stake of 7,433 shares — an estimated $246K sold.

Osaic Holdings first reported a position in VIVO in Q1 2020 and held it in 12 quarters. The position peaked at $1.52M in Q2 2022. 2 funds tracked by Wall St. Rank hold VIVO as of Q1 2023.

  • Osaic Holdings reported no remaining Meridian Bioscience Inc position as of Q1 2023 after selling out during the quarter.
  • Osaic Holdings sold 7,433 Meridian Bioscience Inc shares in Q1 2023, an estimated $246K.
  • Osaic Holdings first reported a position in Meridian Bioscience Inc in Q1 2020 and held it in 12 quarters.
  • Osaic Holdings's Meridian Bioscience Inc position peaked at $1.52M in Q2 2022.
  • 2 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q1 2023.

Based on Osaic Holdings's 13F filing for Q1 2023, filed 12 May 2023.